Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company using protein dynamics to develop precision cancer therapies is acquiring a drug discovery… https://t.co/AzEb3ERy5f
    about 5 hours ago
  • New post on Science and Enterprise: AI Drug Discovery Company Acquired in $270M Deal https://t.co/GhPSuGMAHO #Science #Business
    about 5 hours ago
  • Drug maker Eli Lilly and Co. asked the Food and Drug Administration to revoke its authorization for bamlanivimab al… https://t.co/xtrdcKMDgx
    about 11 hours ago
  • New post on Science and Enterprise: Lilly Asks FDA to Revoke Covid-19 Therapy Clearance https://t.co/FNA6Qlklwy #Science #Business
    about 11 hours ago
  • Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in firs… https://t.co/AMeVYLYh30
    about 1 day ago

Please share Science & Enterprise

Harvard Institute, Sony to Partner on Organs-on-Chips

Gut-on-a-chip (Wyss Institute, Harvard University)

Gut-on-a-chip (Wyss Institute, Harvard University)

The Wyss Institute for Biologically Inspired Engineering at Harvard University in Massachusetts and Sony Corporation’s optical media division (Sony DADC) will collaborate on developing plastic chips that emulate human organs. Financial terms and timetable of the deal were not disclosed.

Chips that emulate human organs are made of clear, flexible polymer plastic, about the size of a flash memory stick, having microfluidic channels lined with living human cells. These organ-on-chip devices make it possible to simulate and observe living cellular functions in real time. Development of these chips can allow preclinical drug testing under more controlled conditions, without the use of lab animals. They can also be used to test for potential harmful effects in chemicals or cosmetics.

NIH says more than 30 percent of promising medications failed when found to be toxic in human clinical trials, despite promising preclinical studies that test the compounds on animals. Organ-on-chip devices, which are a newer human cell-based approach, may help researchers better predict how effective a therapeutic candidate would be in clinical studies.

In July 2012, National Institutes of Health (NIH), with Food and Drug Administration and Defense Advanced Research Projects Agency, announced $70 million in funding for 17 research initiatives to develop organs-on-chips, including a grant to the Wyss Institute. Ten of the projects are building chips emulating organs, while the other seven studies are exploring stem and precursor cells that differentiate into multiple cell types as a source of tissue cells to populate the devices.

In March 2012, Wyss Institute researchers published a paper describing a “gut-on-a-chip” that emulates a human intestine. The device (pictured at top) has a central chamber with a layer of human intestinal epithelial cells growing on a porous membrane substrate that recreates the intestinal barrier. The flexible membrane attaches to side walls that stretch and recoil with the aid of an attached vacuum controller. The institute says it is working on nine other organ-on-chip devices.

Sony DADC builds devices and systems for optical media, such as CDs and DVDs, but has branched into microstructured polymer devices for life science and in-vitro diagnostics. The company plans to bring its expertise on manufacturing to the partnership.

Read more:

*     *     *

1 comment to Harvard Institute, Sony to Partner on Organs-on-Chips